(VIANEWS) – The NASDAQ ended the session with Xenetic Biosciences jumping 6.74% to $0.80 on Thursday, after five sequential sessions in a row of gains. NASDAQ dropped 1.33% to $11,028.74, after three successive sessions in a row of losses, on what was an all-around negative trend exchanging session today.
Today’s last reported volume for Xenetic Biosciences is 25829, 85.25% below its average volume of 175119.
Xenetic Biosciences’s last close was $0.75, 86.84% below its 52-week high of $5.68.
Xenetic Biosciences’s Sales
Xenetic Biosciences’s sales growth is 72.4% for the ongoing quarter and a decline by 33.8% for the next. The company’s growth estimates for the current quarter and the next is 90% and 6.3%, respectively.
Xenetic Biosciences’s Revenue
Year-on-year quarterly revenue growth grew by 154.7%, now sitting on 746.09k for the twelve trailing months.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,
Xenetic Biosciences’s stock is considered to be oversold (<=20).
Xenetic Biosciences’s Stock Yearly Top and Bottom Value
Xenetic Biosciences’s stock is valued at $0.80 at 18:11 EST, way under its 52-week low of $1.21.
Xenetic Biosciences’s Moving Average
Xenetic Biosciences’s value is way under its 50-day moving average of $1.64 and way below its 200-day moving average of $2.19.
More news about Xenetic Biosciences (XBIO).